Christopher M. Frampton
Christchurch, CAN, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phosphodiesterase 9 Inhibition Combined With Valsartan and With Sacubitril/Valsartan in Experimental Ovine Heart Failure.
Journal: Journal of the American Heart Association
Published: November 22, 2024
Augmentation of Natriuretic Peptide Bioactivity via Combined Inhibition of Neprilysin and Phosphodiesterase-9 in Heart Failure.
Journal: JACC. Heart failure
Published: August 10, 2022
ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
Journal: Clinical chemistry
Published: February 04, 2019
High-Sensitivity Sandwich ELISA for Plasma NT-proUcn2: Plasma Concentrations and Relationship to Mortality in Heart Failure.
Journal: Clinical chemistry
Published: December 07, 2015
Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
Journal: European journal of heart failure
Published: March 14, 2015
Human muscle sympathetic nerve responses to urocortin-2 in health and stable heart failure.
Journal: Clinical and experimental pharmacology & physiology
Published: October 12, 2014
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
Journal: PloS one
Published: August 24, 2014
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.
Journal: European heart journal
Published: March 08, 2014
Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy).
Journal: JACC. Heart failure
Published: April 15, 2013
A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.
Journal: American journal of hypertension
Published: November 25, 2011
Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
Journal: Pathology international
Published: October 28, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026